When the healthcare giant reports earnings Thursday morning, investors will be looking to see if Brian Thompson’s death and the public outcry over denials are prompting any changes at the company.

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

The company is at a pivotal point following the killing of Brian Thompson, who headed the UnitedHealthcare unit, and there was a public outcry about insurance denials. That prompted Andrew Witty, the ...